Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions
about
sameAs
Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and backClassification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugsA case of levocetirizine-induced fixed drug eruption and cross-reaction with piperazine derivativesRisk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization StatementDRESS syndrome from cefadroxil confirmed by positive patch test.Usefulness of In Vivo and In Vitro Diagnostic Tests in the Diagnosis of Hypersensitivity Reactions to Quinolones and in the Evaluation of Cross-Reactivity: A Comprehensive Study Including the Latest Quinolone Gemifloxacin.Beta-lactam antibiotic sensitization and its relationship to allergic diseases in tertiary hospital nurses.A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergyClinical features of fixed drug eruption at a tertiary hospital in Korea.Baboon syndrome induced by hydroxyzine.Contact urticaria from Emla cream.Mechanisms in cutaneous drug hypersensitivity reactions.Clinical applications of drug desensitization in the Asia-Pacific region.A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivityInternational survey on skin patch test procedures, attitudes and interpretation.The time delay between drug intake and bronchospasm for nonsteroidal antiinflammatory drugs sensitive patients.Allergological approach to drug hypersensitivity reactions.Patch testing and cross sensitivity study of adverse cutaneous drug reactions due to anticonvulsants: A preliminary report.Patch testing in non-immediate drug eruptions.Immunological aspects of nonimmediate reactions to beta-lactam antibiotics.Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.Patch testing in fixed drug eruptions--a 20-year review.Educational case series: β-lactam allergy and cross-reactivity.Evaluation of antibiotic allergy: the role of skin tests and drug challenges.Tests for evaluating non-immediate allergic drug reactions.Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis.Allergic reactions to local anesthetics in dental patients: analysis of intracutaneous and challenge tests.Review of the 94th Annual Meeting of the British Association of Dermatologists, Glasgow 2014.EAACI position paper for practical patch testing in allergic contact dermatitis in children.Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group.The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests.Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.Evolution of diagnostic approaches in betalactam hypersensitivity.Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis.Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital.Patch testing - a valuable tool for investigating non-immediate cutaneous adverse drug reactions to antibiotics.Update on the management of antibiotic allergyDiagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.A clinical decision-making algorithm for penicillin allergy.
P2860
Q26784638-4CF2AB86-3D95-466B-A954-11BD11F40192Q28300126-40AEE7F3-58E4-42DE-9E6A-A0A486E7CCEDQ28661628-1307C47F-FE98-4627-BCBD-62C53A5A6FC5Q30371972-9470DC41-4813-40F9-93A9-E3B7F6FC4090Q33288181-D1655DE0-E0A9-4213-B8B2-D3073223D0A1Q33734355-83F301A2-3121-4BC0-BA43-B98864F6AF0AQ33758102-0CF06472-D2C7-4729-B0B2-364D135EA761Q33974514-4EA043BF-A1F7-4C15-8E9F-C35960B432DEQ34167916-ADDC35A3-337B-4C25-9446-A13EC6D4912DQ34347787-0DC68733-4034-4480-8EAC-58C863DDB277Q34553543-98B7313B-D215-46D5-91ED-AA01784584F1Q35177407-B1E254C7-8B2C-4F73-B23C-F9D1556EACBCQ35502326-02B1C147-544D-478A-B97E-E548974EC59FQ36370958-4B21F3BD-6D12-4A93-98A8-D07E56540883Q36651675-AEF88FA3-9957-40C9-B4C9-648F9B427BBCQ36834723-0224522B-2EB5-404A-8829-381B47B93767Q37060546-8B0721B5-A37A-414F-A7F1-DAE05EBED83EQ37721702-3FAFBB37-0B25-4736-8D40-0C60864E5FD7Q37762860-FEBA315A-FC58-4F22-A761-124BEE58D4E9Q37786631-42C241E3-A870-4375-8773-AE1FF3A1800BQ37811004-E0D64E19-1985-4F40-B4D1-F83086B0766CQ37894119-60C0B703-61CE-4C03-B000-F9895E8196ECQ37935068-B2E8C756-06F1-442B-A9C1-29766D48E81BQ38241731-25042947-EBE0-4341-8C85-D39971033801Q38258564-47AE458D-C129-464A-B583-500E9A71287BQ38343365-0EE591B8-3BEF-4580-925A-0B211FBC1D87Q38369911-13763F14-A12E-4B17-9C43-F318DAD430DBQ38473549-98A7C859-5DCA-478B-B3FE-8465E001D988Q38569400-190DE3F0-927A-416E-8FB5-BD5C2629439FQ38594812-ED97E962-C27B-4E56-A7CD-D66B8E25A472Q38637036-EB4AB7D0-BB1D-4B4B-9860-9F8EE7746055Q38668592-B489BC74-90BC-41E5-8AAF-37E229A90980Q38805641-2A7F60CA-2710-4061-A62C-98126884B7D0Q39218645-ADD9C339-0062-440C-BA71-AA0098AE4847Q39223693-307CD5AA-EA87-41F7-877E-4C5EEEE23F65Q39382537-13D7D0A6-167D-4012-BD53-A1ECAF4A1754Q39539642-1E1474B1-3111-4544-80CA-26F9576A7A64Q39830842-9418BBCE-8D0A-4EF4-8575-D9414278362FQ39966338-E6F99F5E-421D-4AF6-A1E1-ACA6B851948CQ40078609-AA786E28-F8C7-47B2-A205-4DB35830CB54
P2860
Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Guidelines for performing skin ...... taneous adverse drug reactions
@ast
Guidelines for performing skin ...... taneous adverse drug reactions
@en
Guidelines for performing skin ...... taneous adverse drug reactions
@nl
type
label
Guidelines for performing skin ...... taneous adverse drug reactions
@ast
Guidelines for performing skin ...... taneous adverse drug reactions
@en
Guidelines for performing skin ...... taneous adverse drug reactions
@nl
prefLabel
Guidelines for performing skin ...... taneous adverse drug reactions
@ast
Guidelines for performing skin ...... taneous adverse drug reactions
@en
Guidelines for performing skin ...... taneous adverse drug reactions
@nl
P2093
P3181
P1433
P1476
Guidelines for performing skin ...... taneous adverse drug reactions
@en
P2093
P3181
P356
10.1034/J.1600-0536.2001.450601.X
P407
P577
2001-12-01T00:00:00Z